Tissue Regenix Group plc (AIM:TRX)
London
· Delayed Price · Currency is GBP · Price in GBX 29.50
+0.45 (1.53%)
Jun 27, 2025, 4:35 PM GMT+1
Tissue Regenix Group Revenue
In the year 2024, Tissue Regenix Group had annual revenue of $28.65M USD, down -2.87%. Tissue Regenix Group had revenue of $16.40M in the half year ending June 30, 2024, with 38.58% growth.
Revenue
$28.65M
Revenue Growth
-2.87%
P/S Ratio
0.92
Revenue / Employee
$349.34K
Employees
82
Market Cap
21.01M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 28.65M | -847.00K | -2.87% |
| Dec 31, 2023 | 29.49M | 5.02M | 20.50% |
| Dec 31, 2022 | 24.48M | 4.73M | 23.95% |
| Dec 31, 2021 | 19.75M | 3.27M | 19.87% |
| Dec 31, 2020 | 16.47M | -788.11K | -4.57% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Jan 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |
Tissue Regenix Group News
- 10 months ago - Tissue Regenix Group PLC (FRA:LSW) (Q2 2024) Earnings Call Transcript Highlights: Strong ... - GuruFocus